Matches in Wikidata for { <http://www.wikidata.org/entity/Q65388243> ?p ?o ?g. }
Showing items 1 to 35 of
35
with 100 items per page.
- Q65388243 description "clinical trial" @default.
- Q65388243 description "ensayu clínicu" @default.
- Q65388243 description "klinisch onderzoek" @default.
- Q65388243 description "клінічне випробування" @default.
- Q65388243 name "A Study Of Rosiglitazone Plus Insulin To Treat Type 2 Diabetes Mellitus Patients" @default.
- Q65388243 name "A Study Of Rosiglitazone Plus Insulin To Treat Type 2 Diabetes Mellitus Patients" @default.
- Q65388243 type Item @default.
- Q65388243 label "A Study Of Rosiglitazone Plus Insulin To Treat Type 2 Diabetes Mellitus Patients" @default.
- Q65388243 label "A Study Of Rosiglitazone Plus Insulin To Treat Type 2 Diabetes Mellitus Patients" @default.
- Q65388243 prefLabel "A Study Of Rosiglitazone Plus Insulin To Treat Type 2 Diabetes Mellitus Patients" @default.
- Q65388243 prefLabel "A Study Of Rosiglitazone Plus Insulin To Treat Type 2 Diabetes Mellitus Patients" @default.
- Q65388243 P1050 Q65388243-73027285-E6E9-409D-ACF0-86D0D84D14C0 @default.
- Q65388243 P1132 Q65388243-6C5F911A-B443-4793-97E1-5B318C6516F3 @default.
- Q65388243 P1476 Q65388243-5AD6240A-5505-4BEE-89C6-541976CC393A @default.
- Q65388243 P2899 Q65388243-EE47A589-AE93-4E2A-A051-9391B1324E63 @default.
- Q65388243 P3098 Q65388243-6E42519E-3BA0-4AE5-854B-06F525BAB761 @default.
- Q65388243 P31 Q65388243-B67FA75D-3DCE-4881-B70A-7C1E15CB919C @default.
- Q65388243 P4135 Q65388243-DC8CF743-A82A-4ECF-B9D8-8430B487C2CF @default.
- Q65388243 P580 Q65388243-632C607B-577A-41C9-A52D-2DCE58C12864 @default.
- Q65388243 P6099 Q65388243-27258177-2778-47F5-8EAD-DAA5709C51DC @default.
- Q65388243 P6153 Q65388243-BBE332FE-48F4-4B71-BC05-F58C52EA39FD @default.
- Q65388243 P8363 Q65388243-8B814D04-7205-48E3-B665-9124C068D834 @default.
- Q65388243 P859 Q65388243-38D2DCF0-5B9F-46D6-A5AB-D1EC9A16B1C5 @default.
- Q65388243 P1050 Q12206 @default.
- Q65388243 P1132 "+256" @default.
- Q65388243 P1476 "A Randomized, Double-Blind, Placebo-Control, Clinical Evaluation of Insulin Plus Rosiglitazone Compared to Insulin Plus Placebo for 24 Weeks in Subjects With Type 2 Diabetes Mellitus Who Are Inadequately Controlled On Insulin" @default.
- Q65388243 P2899 "+18" @default.
- Q65388243 P3098 "NCT00349427" @default.
- Q65388243 P31 Q30612 @default.
- Q65388243 P4135 "+70" @default.
- Q65388243 P580 "2005-10-01T00:00:00Z" @default.
- Q65388243 P6099 Q42824827 @default.
- Q65388243 P6153 Q212322 @default.
- Q65388243 P8363 Q78089383 @default.
- Q65388243 P859 Q212322 @default.